These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18045263)

  • 41. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
    Göhring K; Mikeler E; Jahn G; Rohde F; Hamprecht K
    Antivir Ther; 2008; 13(3):461-6. PubMed ID: 18572760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.
    Kibona SN; Matemba L; Kaboya JS; Lubega GW
    Trop Med Int Health; 2006 Feb; 11(2):144-55. PubMed ID: 16451338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two-round allele specific-polymerase chain reaction: a simple and highly sensitive method for JAK2V617F mutation detection.
    Kannim S; Thongnoppakhun W; Auewarakul CU
    Clin Chim Acta; 2009 Mar; 401(1-2):148-51. PubMed ID: 19135044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trypanocidal failure suggested by PCR results in cattle field samples.
    Gall Y; Woitag T; Bauer B; Sidibe I; McDermott J; Mehlitz D; Clausen PH
    Acta Trop; 2004 Sep; 92(1):7-16. PubMed ID: 15301970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A nucleoside transporter from Trypanosoma brucei involved in drug resistance.
    Mäser P; Sütterlin C; Kralli A; Kaminsky R
    Science; 1999 Jul; 285(5425):242-4. PubMed ID: 10398598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards developing a diagnostic regimen for the treatment follow-up of Trypanosoma brucei gambiense.
    Mbati PA; Hirumi K; Inoue N; Situakibanza NH; Hirumi H
    Korean J Parasitol; 1999 Dec; 37(4):289-92. PubMed ID: 10634047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up.
    Truc P; Jamonneau V; Cuny G; Frézil JL
    Bull World Health Organ; 1999; 77(9):745-8. PubMed ID: 10534898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypanosoma brucei gambiense: study of population genetic structure of Central African stocks using amplified fragment length polymorphism (AFLP).
    Simo G; Cuny G; Demonchy R; Herder S
    Exp Parasitol; 2008 Feb; 118(2):172-80. PubMed ID: 17850792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different allele frequencies in Trypanosoma brucei brucei and Trypanosoma brucei gambiense populations.
    Paindavoine P; Zampetti-Bosseler F; Coquelet H; Pays E; Steinert M
    Mol Biochem Parasitol; 1989 Jan; 32(1):61-71. PubMed ID: 2563145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis.
    Mumba Ngoyi D; Lejon V; N'Siesi FX; Boelaert M; Büscher P
    Trop Med Int Health; 2009 Apr; 14(4):438-44. PubMed ID: 19228348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melarsoprol Resistance in African Trypanosomiasis.
    Fairlamb AH; Horn D
    Trends Parasitol; 2018 Jun; 34(6):481-492. PubMed ID: 29705579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis.
    Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity.
    Jeacock L; Baker N; Wiedemar N; Mäser P; Horn D
    PLoS Pathog; 2017 Mar; 13(3):e1006307. PubMed ID: 28358927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trypanosoma brucei gambiense in domestic livestock of Kogo and Mbini foci (Equatorial Guinea).
    Cordon-Obras C; Berzosa P; Ndong-Mabale N; Bobuakasi L; Buatiche JN; Ndongo-Asumu P; Benito A; Cano J
    Trop Med Int Health; 2009 May; 14(5):535-41. PubMed ID: 19320872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon.
    Njiokou F; Laveissière C; Simo G; Nkinin S; Grébaut P; Cuny G; Herder S
    Infect Genet Evol; 2006 Mar; 6(2):147-53. PubMed ID: 16236560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic variability within Trypanosoma brucei gambiense: evidence for the circulation of different genotypes in human African trypanosomiasis patients in Côte d'Ivoire.
    Truc P; Ravel S; Jamonneau V; N'Guessan P; Cuny G
    Trans R Soc Trop Med Hyg; 2002; 96(1):52-5. PubMed ID: 11925992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of Trypanosoma brucei stocks using PCR-RFLP analysis of ribosomal internal transcribed spacers (IRT).
    Tilley A; Hide G
    Ann Trop Med Parasitol; 2001 Sep; 95(6):617-21. PubMed ID: 11672467
    [No Abstract]   [Full Text] [Related]  

  • 60. Diagnostic potential of a conserved genomic rearrangement in the Trypanosoma brucei gambiense-specific TGSGP locus.
    Felu C; Pasture J; Pays E; Pérez-Morga D
    Am J Trop Med Hyg; 2007 May; 76(5):922-9. PubMed ID: 17488917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.